Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure

-Team will focus on global NanoFlu licensure and evaluation of post-pandemic influenza/COVID-19 combination vaccine with NVX-CoV2373
-Russell (Rip) Wilson promoted to Executive Vice President and NanoFlu General Manager

... as the exploration of a combined influenza/COVID-19 vaccine that could be used in a post-pandemic setting...  

https://ir.novavax.com/news-releases/...ygvjDPXL8L6X-SXcaLyVgA2UtEpDo  

wird sicher erst in 2-3 Jahren kommen, da ist die Pandemie schon vorbei und der Markt geflutet von Corona Vakzinen, aber der Markt bzw. die US Aktionäre reagieren derzeit Poitiv auf alles was von den Amerikanischen Biotechs so lanciert wird.

Erstmal muss Novavax sein Single Corona Vakzine final getestet und dann genehmigt bekommen und das dauert auch noch. Das ist ja ganz tolles Marketing aber nicht mehr, denn auch die anderen Biotechs werden in Zukunft kombinierte Grippe/Corona Impfungen anbieten, aber derzeit ist der Focus erstmal drauf überhaupt ein Corona Vakzine zu entwickeln und von den Behörden genehmigt zu bekommen. Ich finde solche News von Novavax nicht seriös, aber was tut man nicht alles um seinen Aktienkurs zu pushen und man sieht, es funktioniert in USA bei den US Aktionären ganz gut.....da kann sich Biontech und CureVac eine Scheibe abschneiden bzw. die Beiden sind einfach zu seriös um solch Zukunftsmusik zu lancieren um ihren Aktienkurs zu pushen.....Da kommt so eine News von Biontech
https://www.n-tv.de/politik/...er-Impfstoff-naht-article22095146.html
und der Aktienkurs bewegt sich gerade mal so um die 5% nach oben. Wenn Novavax so eine News rausgeben würde, dann würde das sicher 100% ++ Anstieg bedeuten ....;-)  

wo die Reise hingeht.


Delighted to welcome Kate Bingham, head of the UK Vaccine Taskforce today who is taking part in the Novavax vaccine trial based at the Royal Free Hospital.

https://twitter.com/royalfreenhs/status/1315986011256651778?s=21


Kate Bingham, Chair of the Government’s Vaccine Taskforce, starts her Novavax trial at the Royal Free Hospital, north London (Picture: PA)

https://metro.co.uk/2020/10/14/...ll-be-ready-for-christmas-13419082/  

At 75, I've volunteered for a Covid vaccine trial. It could set people free.

https://www.theguardian.com/world/2020/oct/24/...ufmxyqXmDKdbsY4TGzIs  

Hallo zusammen =),

Novavax hat ja genauso wie BioNTech und Moderna ihren Impfstoff bereits in Phase III. Ich habe hierzu einmal ein kompaktes Video erstellt, in dem dir die Finanzen, die Produktkandidaten und der aktuelle Status samt Plan für den Covid-19-Impfstoff all dieser Unternehmen dargestellt werden. Anbei der Link:

https://youtu.be/MFDLKd5_zUc

Schönen Sonntag noch =)!  

Novavax redesigns U.K. trial to align with global COVID-19 vaccine trials

...Novavax has modified the U.K. Phase III trial of its COVID-19 vaccine candidate to ensure that it could support EMA approval and, the company believes, potentially support authorization or approval in the U.S.

...While the U.S. trial will be designed to support FDA authorization, Glenn acknowledged that the fast-moving situation, including the possibility that competing vaccines could gain authorization this year, could make it difficult to complete the trial. If that happens, he believes the U.K. trial could support U.S. authorization.

...EMA has told Novavax that the South Africa trial, which includes an arm with HIV positive participants, could potentially support European approval, he added.

https://www.biocentury.com/article/...hxhzfyuiX1jf7LaAqZYfTSGT8-P9s5U  

Novavax: Still Everything To Play For - Expect Plenty Of Data-Driven Volatility

https://seekingalpha.com/article/...gz9u39fo5ngF3_EzlV583UAKWUuPFxTRo  

"  Interessanter Artikel: " ja ,  aber für viele Kleinanleger in meinen Augen  schon etwas
negativ und nicht für den Kurs förderlich
hoffentlich , fallen sie nicht unter 60 Euro
 

Novavax Announces Facility Expansion to Support Global Vaccine Development

https://ir.novavax.com/news-releases/...SXjvLzbl67m38hRtN-CAYyJbtlDug

... Novavax has also created a global production network to enable manufacturing and rapid distribution across the U.S., Asia and Europe if and when its COVID-19 vaccine is approved for use. The Company also reported positive Phase 3 data for its influenza vaccine candidate, NanoFlu, earlier this year...  

https://twitter.com/mesmer21/status/1323108999449976833?s=21

https://pbs.twimg.com/media/ElygBs8XEAAT-Ym.jpg  

Australia signs two more COVID-19 vaccine agreements

...Under the new deals, to be announced on Wednesday, Novavax will supply 40 million vaccine doses and Pfizer/BioNTech will provide 10 million, should the vaccines be proven safe and effective through advanced clinical trials...

https://www.smh.com.au/politics/federal/...ments-20201104-p56biy.html  

Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-binding Heads of Terms document with the Australian Government to supply 40 million doses of the Company’s COVID-19 vaccine candidate, NVX-CoV2373, for the Australian community.

https://ir.novavax.com/news-releases/...o8QPsc4inhmreM1J6XgdY7oRV28r0
 

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

https://ir.novavax.com/news-releases/...fast-track-designation-us-fda  

für den Bericht reinstellen. Heute morgen Biontech , jetzt Novavax. kann es besser laufen??

ich danke dir für den Bericht  

Booom - so zerstört's die Aktie!    Das Schöne - mann  kann short gehen!

One promising contender has emerged from a biotech company that has never brought a vaccine to market.

https://twitter.com/novavax/status/1329052895149486080?s=21  

‘dysfunctional’ approach to Covid-19 vaccine distribution

... He said the vaccines likely to reach the market a bit after the initial shots could have advantages. While Pfizer and Moderna have been the first companies to report early, encouraging results in late-stage clinical trials of their mRNA vaccines, Gates said the levels of antibodies elicited are much higher in more conventional vaccines being developed by Novavax and Johnson & Johnson; AstraZeneca’s comes in a little below the mRNA ones. Gates also said the cold-chain requirements and the cost of scaling up mRNA vaccine production “is not as attractive” as the other approaches.

“The fact that Novavax and J&J are above Pfizer makes us very hopeful that in the first quarter [of 2021] those vaccines will get approved and those we can make in many hundreds of millions per month in these developing world factories.”...

https://www.statnews.com/2020/11/17/...covid-19-vaccine-distribution/  

Good discussion with leaders. The @EU_Commission  is broadening its vaccines portfolio, with discussions ongoing with Moderna & Novavax.

We will continue coordinating our efforts to keep citizens informed on vaccination & safe.

https://twitter.com/vonderleyen/status/1329523471706152964?s=21  

https://youtu.be/dexryZiV-tg  

was denkst du , wann kommen hier neue positive Nachrichten ???  

noch heute:

http://ih.advfn.com/...p;width=800&vol=1&height=400&Vol=1

Ich denke das können wir noch dieses Jahr erwarten:

-96-98% Wirksamkeit
-EU Deal

Lass uns die Daumen drücken, denn dann geht es hier steil, nur meine Meinung.  

der schnelle Anstieg  und die hohen Stückzahlen , die in usa gekauft werden lässt mich hoffen ,
dass es wieder hochgeht  

https://twitter.com/sciencemagazine/status/1330164137289244673?s=21  

a COVID-19 Vaccine

Seite 16 und 17

https://assets.publishing.service.gov.uk/...5sLFQ5_5mwsIesWr_Tr1iftD4